Warfarin News and Research

RSS
Warfarin is a drug that prevents blood from clotting. It belongs to the family of drugs called anticoagulants (blood thinners).
Newer anticoagulant may be safer for dialysis patients with Afib

Newer anticoagulant may be safer for dialysis patients with Afib

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

New studies could offer novel treatments for vision and eye conditions

New studies could offer novel treatments for vision and eye conditions

Annual foot screening could help spot heart irregularities in people with diabetes

Annual foot screening could help spot heart irregularities in people with diabetes

Herbal products may affect properties of prescription drugs and lead to dangerous side effects

Herbal products may affect properties of prescription drugs and lead to dangerous side effects

Study: Non-vitamin K antagonist oral anticoagulants linked to reduced kidney risks

Study: Non-vitamin K antagonist oral anticoagulants linked to reduced kidney risks

Genetic testing can improve safety of common blood thinner, study shows

Genetic testing can improve safety of common blood thinner, study shows

Two anticlotting medicines better at reducing bleeding risk than triple therapy

Two anticlotting medicines better at reducing bleeding risk than triple therapy

Researchers develop new scoring method to predict bleeding risk after stroke

Researchers develop new scoring method to predict bleeding risk after stroke

Anti-allergy medicines may be effective treatment for deadly blood clots in the legs

Anti-allergy medicines may be effective treatment for deadly blood clots in the legs

GPs prescribing anticoagulants to AF patients against official safety advice, study shows

GPs prescribing anticoagulants to AF patients against official safety advice, study shows

Paroxysmal AF patients less likely to be prescribed anticoagulants for stroke prevention, study finds

Paroxysmal AF patients less likely to be prescribed anticoagulants for stroke prevention, study finds

Rush offers new, implantable cardiac device to reduce risk of stroke in AFib patients

Rush offers new, implantable cardiac device to reduce risk of stroke in AFib patients

Study: 1 in 6 patients on new blood-thinning medications may not be receiving recommended dose

Study: 1 in 6 patients on new blood-thinning medications may not be receiving recommended dose

Therapeutic small molecules safely prevent blood clots without excessive bleeding

Therapeutic small molecules safely prevent blood clots without excessive bleeding

Long-term aspirin therapy shows no benefit for stroke reduction in low risk AF patients, study finds

Long-term aspirin therapy shows no benefit for stroke reduction in low risk AF patients, study finds

Delayed anticoagulation treatment for atrial fibrillation patients increases dementia risk, study finds

Delayed anticoagulation treatment for atrial fibrillation patients increases dementia risk, study finds

Inhealthcare and Roche Diagnostics partnership brings new innovation to self-testing market

Inhealthcare and Roche Diagnostics partnership brings new innovation to self-testing market

Survey shows nearly 90% of patients on warfarin would like to self-monitor

Survey shows nearly 90% of patients on warfarin would like to self-monitor

Scientists identify new gene that drives drug resistance in breast cancer

Scientists identify new gene that drives drug resistance in breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.